• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

Target Angiogenesis for Lung Cancer With Multiple Tyrosine Kinase Inhibitors

  • — 17 Mar, 2008
AudioMedica News
AudioMedica News
Target Angiogenesis for Lung Cancer With Multiple Tyrosine Kinase Inhibitors
Target Angiogenesis for Lung Cancer With Multiple Tyrosine Kinase Inhibitors
00:00 /
RSS Feed
Share
Link
Embed
Silvia Novello
Silvia Novello

SILVIA NOVELLO, University of Turin
Future improvements in drug treatment of lung cancer may be made by inhibiting more than one tyrosine kinase simultaneously. So said Silvia Novello when she presented data on a range of drugs which target angiogenesis by inhibiting more than one tyrosine kinase pathway. She talked about the evidence so far with Peter Goodwin.



LISTEN

[audio:https://www.audiomedica.com/podcasting/oncology/080317_silvia_novello.mp3]

You may also like...

  • Fewer, Not More, Live Births After Preimplantation Genetic Embryo Screening – reporting from European Society of Human Reproduction and Embryology 23rd Annual Meeting, Lyon, July 1-4, 2007 Fewer, Not More, Live Births After Preimplantation Genetic Embryo Screening – reporting from European Society of Human Reproduction and Embryology 23rd Annual Meeting, Lyon, July 1-4, 2007 4 Jul, 2007
  • Audio Journal of Medicine: Reporting from the 2006 Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, San Francisco Audio Journal of Medicine: Reporting from the 2006 Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, San Francisco 1 Oct, 2006
  • New Drug AMG 531 Effective in Splenectomized Patients with Chronic Immune Thrombocytopenic Purpura New Drug AMG 531 Effective in Splenectomized Patients with Chronic Immune Thrombocytopenic Purpura 9 Dec, 2007
  • GnRH Antagonist Protects Ovarian Function During Chemotherapy GnRH Antagonist Protects Ovarian Function During Chemotherapy 2 Aug, 2007
  • Previous story Bevacizumab: New Standard for Non-Small Cell Lung Cancer?
  • Next story New Targets Bring Promise For Lung Cancer Therapy
  • News

    • Mandeep Mehra MDCOVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
    • Ultrahypofractionated Radiation Just As Effective for Prostate CancerUltrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
  • Related interviews

    • Ibrutinib: New Frontline Standard for Chronic Lymphocytic…
    • Microbiome Diversity Key To Survival After Allogeneic…
    • Genomic-led AML Clinical Decision Making Within Seven Days
    • New Front Line Standard for Older Patients with Chronic…
    • CT Screening Cuts Lung Cancer Deaths 24 Per Cent—Second…
  • Home
  • General Medicine
  • Target Angiogenesis for Lung Cancer With Multiple Tyrosine Kinase Inhibitors

© Copyright 2022 AudioMedica.com. Typegrid Theme by WPBandit.